Xilio Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Xilio Therapeutics, Inc.

Welcome to our dedicated page for Xilio Therapeutics, Inc. (Nasdaq: XLO) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Xilio Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Xilio Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for XLO
TickerTime & DateFilingLink
XLO10:50:01 PM, 4/3/2024
GILEAD SCIENCES, INC. purchased 485250 shares of Xilio Therapeutics, Inc. (XLO) for ~$368790
Filing
XLO9:33:08 PM 2/9/2024
Atlas Venture Fund XI, L.P. sold 1000 shares of Xilio Therapeutics, Inc. (XLO) for ~$639
Filing
XLO11:16:18 PM 1/16/2024
Atlas Venture Fund XI, L.P. sold 4235 shares of Xilio Therapeutics, Inc. (XLO) for ~$3599
Filing